SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-18-017902
Filing Date
2018-10-03
Accepted
2018-10-03 16:22:42
Documents
1
Period of Report
2018-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 2737
  Complete submission text file 0001437749-18-017902.txt   4446
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 420 LEXINGTON AVE., SUITE 300 NEW YORK NY 10170
Business Address
Hornung William Karl (Reporting) CIK: 0001612066 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 181105291